CME webinar: Pediatric Asthma Management Guidelines
Jul. 2022Education/Webinars
"Please join us for a live, CME-accredited webinar Wednesday, Aug. 24, from noon to 1 p.m. The presentation will include an overview of the latest 2020 Pediatric Asthma Management Guidelines, including:
Presenters:
Register now at upmchp.us/asthma. This webinar will be recorded.
You may earn continuing medical education (CME) credits for attending this webinar.*
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility."
- The use of as-needed courses of inhaled corticosteroids in the management of mild persistent asthma.
- The use of single-inhaler maintenance and reliever therapy (SMART) in moderate persistent asthma.
- Strategies and potential barriers to the implementation of new asthma management guidelines.
- Sharing UPMC Health Plan asthma resources.
Presenters:
- Erick Forno, MD, MPH, ATSF, Director, CHP Pediatric Asthma Center Division of Pediatric Pulmonary Medicine at UPMC Children’s Hospital of Pittsburgh/University of Pittsburgh School of Medicine
- Deborah Moss, MD, MPH, FAAP, Professor of Pediatrics, University of Pittsburgh Children’s Hospital of Pittsburgh of UPMC Division of General Academic Pediatrics; Pediatric Medical Director, UPMC for You; and Medical Director, UPMC for Kids
- Erin McConnell, PharmD, Program Manager, Pharmacy Quality, UPMC Health Plan
Register now at upmchp.us/asthma. This webinar will be recorded.
You may earn continuing medical education (CME) credits for attending this webinar.*
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility."
Recent Announcements
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices
Important announcement – Telehealth submissions
As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.Sep. 2025Important Notices